Product Code: GVR-4-68040-022-7
Artificial Corneal Implants Market Growth & Trends:
The global artificial corneal implants market size is expected to reach USD 118.3 billion by 2030, registering a CAGR of 7.1% from 2023 to 2030, as per a new report by Grand View Research Inc. Introduction of new products in the market that are aimed to reduce the post-surgery complications is the key factor driving the growth of the artificial corneal implants market.
In addition, the continuously growing patient pool and lack of human cornea donors create a huge demand and supply gap. Thus, in order to reduce this gap, manufacturers in the market are vigorously conducting research to introduce new products that will be able to address this shortage in the coming years.
Moreover, the high risk of transplant rejection, post the transplantation of human cornea, is also helping the market to grow at a significant rate. On the other hand, increasing corneal disorders that require a corneal transplant, as well as rising awareness regarding artificial corneal implants in Asia Pacific, are factors expected to boost market growth over the forecast period.
The COVID-19 pandemic had a significant negative impact on the market due to reduced hospital visits that resulted in a fall in the number of diagnosed patients that require a corneal transplant. In addition, the lockdowns and strict restrictions imposed by governments and the increased focus of healthcare professionals to treat COVID-19 patients also resulted in a drop in the number of transplantation surgeries carried out during the pandemic.
However, with everything moving towards normalcy and the huge demand-supply gap created as a result of the pandemic, the demand for artificial corneal implants is expected to soar. Moreover, with the expected launch of new products in 2023, the market is further expected to experience great sales opportunities over the forecast period.
Artificial Corneal Implants Market Report Highlights:
- The hard keratoprosthesis segment held the highest market share in 2022 owing to an increasing adoption rate
- The soft keratoprosthesis segment is projected to experience maximum growth over the forecast period due to expected new product launches
- The keratoconus segment dominated the market with the largest revenue share in 2022 owing to the increasing prevalence and rising adoption of artificial corneal implants for this indication
- The Ocular Cicatricial Pemphigoid (OCP) segment is predicted to undergo maximum growth owing to new product launches for this indication
- Synthetic implants held the highest market share in 2022 owing to the easy availability of these products
- The hospitals segment accounted for the highest market share in 2022 owing to a large number of transplantation procedures being carried out in these facilities
- The ambulatory surgical centers are expected to render the highest growth over the forecast period due to the increasing number of patients opting for such facilities because of their advantages
- North America dominated the market due to the high penetration rate of technologically advanced products and the presence of a large patient pool
- Growing awareness regarding corneal diseases, rise in disposable income in Asia Pacific countries, and growing geriatric population is driving the market growth in the region
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Transplant Type
- 1.1.2. Indication
- 1.1.3. Implant Type
- 1.1.4. End - use
- 1.1.5. Regional scope
- 1.1.6. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.2. Approach 1: Commodity flow approach
- 1.6.3. Volume price analysis (Model 2)
- 1.6.4. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Transplant Type Outlook
- 2.2.2. Indication Outlook
- 2.2.3. Implant Type Outlook
- 2.2.4. End - use Outlook
- 2.2.5. Regional Outlook
- 2.3. Competitive Insights
Chapter 3. Artificial Corneal Implants Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rising prevalence of eye diseases
- 3.4.1.2. Huge patient pool and limited supply of donor tissue
- 3.4.2. Market restraint analysis
- 3.4.2.1. Shortage of ophthalmologists
- 3.4.2.2. Complications post - surgery
- 3.5. Artificial Corneal Implants Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Artificial Corneal Implants: Transplant Type Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Hard Keratoprosthesis
- 4.1.2. Soft Keratoprosthesis
- 4.2. Artificial Corneal Implants Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Artificial Corneal Implants Market by Transplant Type Outlook
- 4.5. Market Transplant Type & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Hard Keratoprosthesis
- 4.5.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
- 4.5.1.2. Boston Kpro
- 4.5.1.2.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
- 4.5.1.3. Osteo - Odonto - Keratoprosthesis
- 4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 5. Artificial Corneal Implants: Indication Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Stevens - Johnson Syndrome (SJS)
- 5.1.2. Ocular Cicatricial Pemphigoid (OCP)
- 5.1.3. Ocular Burns
- 5.1.4. Keratoconus
- 5.1.5. Corneal Stromal Dystrophies
- 5.1.6. Others
- 5.2. Indication Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Artificial Corneal Implants Market by Indication Outlook
- 5.5. Market Indication & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Stevens - Johnson Syndrome (SJS)
- 5.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.2. Ocular Cicatricial Pemphigoid (OCP)
- 5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.3. Ocular Burns
- 5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.4. Keratoconus
- 5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.5. Corneal Stromal Dystrophies
- 5.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 5.5.6. Others
- 5.5.6.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 6. Artificial Corneal Implants: Implant Type Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Synthetic
- 6.1.2. Biosynthetic
- 6.2. Implant Type Market Share, 2022 & 2030
- 6.3. Segment Dashboard
- 6.4. Global Artificial Corneal Implants Market by Indication Outlook
- 6.5. Market Indication & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Synthetic
- 6.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
- 6.5.2. Biosynthetic
- 6.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
Chapter 7. Artificial Corneal Implants Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2022 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030:
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8. Europe
- 7.8.1. UK
- 7.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.6. Denmark
- 7.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.7. Sweden
- 7.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.8.8. Norway
- 7.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.2. India
- 7.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.3. China
- 7.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.4. South Korea
- 7.9.41 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.5. Thailand
- 7.9.5.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.9.6. Australia
- 7.9.6.1 Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11. MEA
- 7.11.1. South Africa
- 7.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.2. Saudi Arabia
- 7.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
- 7.11.4. Kuwait
- 7.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.2.1. Innovators
- 8.2.2. Market Leaders
- 8.2.3. Emerging Players
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. FCI Ophthalmics, Inc.
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Product benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Beijing Microkpro Medical Instrument Co. Ltd.
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Product benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. DIOPTEX Medizinprodukte Forschungs
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Product benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. KeraMed, Inc.
- 8.3.7.1. Overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Product benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. EyeYon
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Product benchmarking
- 8.3.8.4. Strategic initiatives